US guidance highlights cardiovascular benefits of hypoglycemic drugs

Cardiologists urged to consider for patients with atherosclerosis and type 2 diabetes

A new report from the American College of Cardiology focuses on how to use novel medications to cut the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes and atherosclerotic cardiovascular disease.